The outlook of companies tied to flagship drugs like Viagra presents a nuanced investment picture. While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial wealth , the Adult patent expiration in key markets has introduced significant risk . Investors are now facing the consequences of generic competition